Illumina vince l'appello accelerato dell'ordine della FTC di cedere Grail -19 aprile 2023 alle 19:14 | MarketScreener
illumina, Inc. | AsymmetricA
Illumina faces record fine over purchase of Grail without EU approval
Sequenziatore di nuova generazione per DNA - NextSeq 550Dx - Illumina, Inc. - da laboratorio / clinico
Signal: Illumina leads $15m investment in Broken String Biosciences - Pharmaceutical Technology
Illumina | Sequencing and array-based solutions for genetic research
ILMN Intrinsic Valuation and Fundamental Analysis - Illumina Inc - Alpha Spread
About Us | A global leader in genomics
Illumina | Sequencing and array-based solutions for genetic research
Illumina Expands Into India - San Diego Business Journal
Illumina Hit With €432 Million EU Fine for Hasty Grail Deal - Bloomberg
Illumina appoints new CEO after battle with investors
Signal: Illumina to divest Grail, ending years-long legal battle - Medical Device Network
Company Overview | An innovative genomics company
Illumina and BlueBee: Unlocking the full potential of genomic insights
Sequenziatore di nuova generazione per DNA - NextSeq 550 - Illumina, Inc. - per RNA / da laboratorio
Company Overview | An innovative genomics company
Illumina-Grail deal heads to FTC trial, as EU weighs penalty | Reuters
Illumina, Inc.
Illumina, Inc. - Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
Insider Buying: Illumina, Inc. (NASDAQ:ILMN) CEO Buys 7,330 Shares of Stock - American Banking and Market News
EU regulators to order Illumina to sell $8bn cancer treatment group
Illumina inc immagini e fotografie stock ad alta risoluzione - Alamy
Illumina, Inc. - Illumina celebrates 25 years of innovation
ILMN prezzo e grafico azione — NASDAQ:ILMN — TradingView
Illumina cuts annual profit forecast as biotech funding woes linger | Reuters
